It’s not about repeat heart attacks. The study was in heart failure patients. The main issue is preventing events like exacerbation of heart failure and sudden

It’s not about repeat heart attacks. The study was in heart failure patients. The main issue is preventing events like exacerbation of heart failure and sudden death. The study looked for a large effect size. That’s totally fine. I think it is good that non-pharmacological interventions are being studied. Calling it crap is quite unfair.